CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will present at the Oppenheimer 25th Annual Healthcare Conference on Thursday, December 11, 2014 at 1:00 p.m. Eastern Time. The conference will take place at Crowne Plaza Times Square Manhattan in New York City.
Help employers find you! Check out all the jobs and post your resume.
